Vanguard Capital Management’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Vanguard Capital Management's SION Position: Q3 2026 in Review
Vanguard Capital Management increased its Sionna Therapeutics (SION) stake by 5.1% in Q3 2026, buying an estimated $1.32M and bringing the position to 1,189,396 shares worth $6.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2998.
Vanguard Capital Management first reported a position in SION in Q1 2026 and has held it in 3 quarters since. The position peaked at $49.8M in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Vanguard Capital Management held 1,189,396 shares of Sionna Therapeutics worth $6.26M as of Q3 2026.
- Vanguard Capital Management bought 57,395 Sionna Therapeutics shares in Q3 2026, an estimated $1.32M.
- Sionna Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2998 holding.
- Vanguard Capital Management first reported a position in Sionna Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Sionna Therapeutics position peaked at $49.8M in Q2 2026.
- 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.